Concepedia

Cassandra Nan

CN

10

Publications

536

Citations

10

H-Index

2013

Active since

Affiliations

AstraZeneca (Sweden)(Current)

GlaxoSmithKline (United Kingdom)

AstraZeneca (United Kingdom)

Imperial College London

Karolinska Institutet

Cassandra Nan is an author at AstraZeneca (Sweden) specializing in medicine, public health, and pediatrics.

ORCID

Top concepts

Publications per year

2013–2024

10

Publications

10

SABINA: An Overview of Short-Acting β2-Agonist Use in Asthma in European Countries

Christer Janson, Andrew Menzies‐Gow, Cassandra Nan et al. · Advances in Therapy · 2020 · 138 citations · Full text

Asthma-Related Health Outcomes Associated with Short-Acting β2-Agonist Inhaler Use: An Observational UK Study as Part of the SABINA Global Program

Chloë I. Bloom, Claudia Cabrera, Sofie Arnetorp et al. · Advances in Therapy · 2020 · 114 citations · Full text

SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting β<sub>2</sub>-agonist use in asthma

Claudia Cabrera, Cassandra Nan, N Lindarck et al. · European Respiratory Journal · 2019 · 60 citations · Full text

, , +15

Oral corticosteroid prescription patterns for asthma in France, Germany, Italy and the UK

Trung N. Tran, Elizabeth G. King, Rajiv Sarkar et al. · European Respiratory Journal · 2020 · 55 citations · Full text

Genomic Analysis Reveals Multi-Drug Resistance Clusters in Group B Streptococcus CC17 Hypervirulent Isolates Causing Neonatal Invasive Disease in Southern Mainland China

Edmondo Campisi, Roberto Rosini, Wenjing Ji et al. · Frontiers in Microbiology · 2016 · 54 citations · Full text

, , +18

Rows per page

1–5 of 10